ArticleFrontiers in chemistry2024

Discovery of novel melatonin-mydroxyquinoline hybrids as multitarget strategies for Alzheimer's disease therapy.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.